Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-tocopherol for Hemolysis in Beta-Thalassemia Major
NCT03948737Completed
- Sponsor
- Universitas Indonesia
- Start
- Dec 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of alpha-tocopherol in beta thalassemia (2 arms), sponsored by Universitas Indonesia. Primary endpoint: The effects of alpha-tocopherol in hemolysis marker on the red cell membrane at 4 weeks. Started Dec 2016; status: completed.
02
Drugs
alpha-tocopherol
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT03948737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948737.